Artal Group S.A.
- SEC CIK
- 0001053906
- Latest filing
- Aug 13, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 13, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 101
- −13 vs. Q2 2023
- Portfolio value
- $2.29B
- −$828.7M (−26.5%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CAVACava Group, Inc. | COM | 32,007,990 | $980.4M | 42.7% | 00.0% | Unchanged | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 117,553,284 | $128.1M | 5.6% | 00.0% | Unchanged | History |
| MRTXMirati Therapeutics, Inc. | COM | 2,024,226 | $88.2M | 3.8% | −30,955−1.5% | Reduced | History |
| ONCBeOne Medicines Ltd. | ADR | 403,934 | $72.7M | 3.2% | −8,562−2.1% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 2,529,737 | $70.0M | 3.1% | +128,120+5.3% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 9,059,507 | $64.3M | 2.8% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,664,572 | $63.3M | 2.8% | +614,505+58.5% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 4,062,567 | $49.4M | 2.2% | −500,000−11.0% | Reduced | History |
| MORFMorphic Holding, Inc. | COM | 2,138,188 | $49.0M | 2.1% | −1,807−0.1% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 1,518,831 | $44.7M | 2.0% | +102,800+7.3% | Added | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 1,816,620 | $42.0M | 1.8% | 00.0% | Unchanged | History |
| NMRANeumora Therapeutics, Inc. | COM | 2,802,702 | $39.5M | 1.7% | +2,802,702 | New | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 1,638,858 | $35.8M | 1.6% | 00.0% | Unchanged | History |
| SLRNACELYRIN, Inc. | COM | 2,469,279 | $25.1M | 1.1% | +648,065+35.6% | Added | History |
| KYMRKymera Therapeutics, Inc. | COM | 1,805,346 | $25.1M | 1.1% | 00.0% | Unchanged | History |
| SLNSilence Therapeutics plc | ADS | 2,500,000 | $24.6M | 1.1% | +800,000+47.1% | Added | History |
| IMGNImmunoGen, Inc. | COM | 1,512,113 | $24.0M | 1.0% | +746,616+97.5% | Added | History |
| IGMSIGM Biosciences, Inc. | COM | 2,522,244 | $21.1M | 0.9% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 2,018,056 | $18.4M | 0.8% | 00.0% | Unchanged | History |
| AGENAgenus Inc | COM NEW | 15,631,235 | $17.7M | 0.8% | 00.0% | Unchanged | History |
| SESea Ltd | SPONSORD ADS | 397,000 | $17.4M | 0.8% | +47,000+13.4% | Added | History |
| DNLIDenali Therapeutics Inc. | COM | 802,899 | $16.6M | 0.7% | 00.0% | Unchanged | History |
| KLRSKalaris Therapeutics, Inc. | COM | 6,597,167 | $14.2M | 0.6% | 00.0% | Unchanged | History |
| SDGRSchrodinger, Inc. | COM | 500,000 | $14.1M | 0.6% | −200,000−28.6% | Reduced | History |
| VTYXVentyx Biosciences, Inc. | COM | 405,239 | $14.1M | 0.6% | −3,280−0.8% | Reduced | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,193,030 | $13.7M | 0.6% | 00.0% | Unchanged | History |
| CBIOCrescent Biopharma, Inc. | COM | 8,589,064 | $12.9M | 0.6% | 00.0% | Unchanged | History |
| RYZBRayzeBio, Inc. | COM | 555,556 | $12.3M | 0.5% | +555,556 | New | History |
| GERNGeron Corp | COM | 5,565,889 | $11.8M | 0.5% | 00.0% | Unchanged | History |
| ROIVRoivant Sciences Ltd. | SHS | 1,000,000 | $11.7M | 0.5% | −625,000−38.5% | Reduced | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 3,663,104 | $11.6M | 0.5% | +2,222,222+154.2% | Added | History |
| WVEWave Life Sciences, Inc. | SHS | 2,000,000 | $11.5M | 0.5% | −870,523−30.3% | Reduced | History |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $10.7M | 0.5% | 00.0% | Unchanged | History |
| SEERSeer, Inc. | COM CL A | 4,750,000 | $10.5M | 0.5% | 00.0% | Unchanged | History |
| VIGLVigil Neuroscience, Inc. | COM | 1,908,135 | $10.3M | 0.4% | −3,056−0.2% | Reduced | History |
| RNACCartesian Therapeutics, Inc. | COM | 9,136,635 | $9.69M | 0.4% | 00.0% | Unchanged | History |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $9.60M | 0.4% | 00.0% | Unchanged | History |
| ERASErasca, Inc. | COM | 4,721,194 | $9.30M | 0.4% | 00.0% | Unchanged | History |
| TSMTaiwan Semiconductor Manufacturing Co Ltd | ADR | 102,699 | $8.93M | 0.4% | +60,199+141.6% | Added | History |
| NTRANatera, Inc. | COM | 200,000 | $8.85M | 0.4% | 00.0% | Unchanged | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $8.75M | 0.4% | 00.0% | Unchanged | History |
| NTLAIntellia Therapeutics, Inc. | COM | 276,077 | $8.73M | 0.4% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $8.60M | 0.4% | 00.0% | Unchanged | History |
| REPLReplimune Group, Inc. | COM | 500,000 | $8.55M | 0.4% | 00.0% | Unchanged | History |
| RPTXRepare Therapeutics Inc. | COM | 700,000 | $8.46M | 0.4% | 00.0% | Unchanged | History |
| SGMTSagimet Biosciences Inc. | COM SER A | 924,771 | $8.14M | 0.4% | +924,771 | New | History |
| IMAImageneBio, Inc. | COM | 1,849,513 | $8.01M | 0.3% | 00.0% | Unchanged | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $7.77M | 0.3% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 504,978 | $7.75M | 0.3% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 815,085 | $7.30M | 0.3% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 500,000 | $6.13M | 0.3% | 00.0% | Unchanged | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 2,046,517 | $5.87M | 0.3% | 00.0% | Unchanged | History |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 1,475,744 | $5.83M | 0.3% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 2,688,015 | $5.70M | 0.2% | 00.0% | Unchanged | History |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 2,533,045 | $5.45M | 0.2% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 6,399,819 | $5.33M | 0.2% | +3,371,648+111.3% | Added | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 1,725,000 | $4.49M | 0.2% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 400,000 | $4.38M | 0.2% | 00.0% | Unchanged | History |
| BEKEKE Holdings Inc. | SPONSORED ADS | 275,000 | $4.27M | 0.2% | −75,000−21.4% | Reduced | History |
| VERVVerve Therapeutics, Inc. | COM | 300,000 | $3.98M | 0.2% | 00.0% | Unchanged | History |
| HOOKHOOKIPA Pharma Inc. | COM | 5,666,410 | $3.49M | 0.2% | 00.0% | Unchanged | History |
| BZKanzhun Ltd | SPONSORED ADS | 220,000 | $3.34M | 0.1% | 00.0% | Unchanged | History |
| TRMLTourmaline Bio, Inc. | COM | 914,262 | $2.57M | 0.1% | 00.0% | Unchanged | History |
| SLDBSolid Biosciences Inc. | COM NEW | 909,219 | $2.29M | 0.1% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $2.05M | 0.1% | 00.0% | Unchanged | – |
| KRONKronos Bio, Inc. | COM | 1,542,954 | $2.01M | 0.1% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 300,000 | $1.91M | 0.1% | 00.0% | Unchanged | – |
| MSFTMicrosoft Corp | Stock | 5,500 | $1.74M | 0.1% | +2,500+83.3% | Added | History |
| VVisa Inc. | Stock | 7,500 | $1.73M | 0.1% | 00.0% | Unchanged | History |
| ADAGAdagene Inc. | ADS | 1,000,000 | $1.53M | 0.1% | 00.0% | Unchanged | History |
| AMZNAmazon Com Inc | Stock | 12,000 | $1.52M | 0.1% | +2,000+20.0% | Added | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 850,000 | $1.12M | <0.1% | 00.0% | Unchanged | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 110,532 | $1.06M | <0.1% | 00.0% | Unchanged | History |
| DDOGDatadog, Inc. | CL A COM | 11,500 | $1.05M | <0.1% | +6,500+130.0% | Added | History |
| XLOXilio Therapeutics, Inc. | COM | 450,000 | $950.0K | <0.1% | 00.0% | Unchanged | History |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 1,133,775 | $884.0K | <0.1% | 00.0% | Unchanged | History |
| GOOGLAlphabet Inc. | Stock | 5,500 | $720.0K | <0.1% | +1,500+37.5% | Added | History |
| CRISCuris Inc | COM | 105,000 | $692.0K | <0.1% | +40,000+61.5% | AddedConverted for a 1-for-20 split | History |
| XYZBlock, Inc. | CL A | 15,500 | $686.0K | <0.1% | +15,500 | New | History |
| MEHCQChrome Holding Co. | CLASS A COM | 661,009 | $646.0K | <0.1% | 00.0% | Unchanged | History |
| AMDAdvanced Micro Devices Inc | Stock | 6,000 | $617.0K | <0.1% | 00.0% | Unchanged | History |
| CRBUCaribou Biosciences, Inc. | COM | 105,347 | $504.0K | <0.1% | 00.0% | Unchanged | History |
| NFLXNetflix Inc | Stock | 1,285 | $485.0K | <0.1% | +1,285 | New | History |
| KRSAKorsana Biosciences, Inc. | Stock | 138,403 | $473.0K | <0.1% | 00.0% | Unchanged | History |
| HARPHarpoon Therapeutics, Inc. | COM NEW | 100,000 | $403.0K | <0.1% | 00.0% | UnchangedConverted for a 1-for-10 split | History |
| CRWDCrowdStrike Holdings, Inc. | Stock | 2,000 | $335.0K | <0.1% | −1,500−42.9% | Reduced | History |
| INTAIntapp, Inc. | COM | 10,000 | $335.0K | <0.1% | +10,000 | New | History |
| PEGAPegasystems Inc | COM | 7,500 | $326.0K | <0.1% | +7,500 | New | History |
| PCORProcore Technologies, Inc. | COM | 4,500 | $294.0K | <0.1% | 00.0% | Unchanged | History |
| LVTXLAVA Therapeutics NV | SHS | 200,000 | $294.0K | <0.1% | 00.0% | Unchanged | History |
| PYPLPayPal Holdings, Inc. | Stock | 5,000 | $292.0K | <0.1% | +5,000 | New | History |
| BEAMBeam Therapeutics Inc. | COM | 10,975 | $264.0K | <0.1% | 00.0% | Unchanged | History |
| HIPOHippo Holdings Inc. | COM NEW | 24,000 | $191.0K | <0.1% | 00.0% | Unchanged | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 936 | $166.0K | <0.1% | 00.0% | Unchanged | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 5,440 | $146.0K | <0.1% | 00.0% | Unchanged | History |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $129.0K | <0.1% | 00.0% | Unchanged | History |
| KAKineta, Inc. | COM | 31,055 | $106.0K | <0.1% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 1,490 | $26.0K | <0.1% | 00.0% | Unchanged | History |
| SNTISenti Biosciences Holdings, Inc. | COM | 55,555 | $23.0K | <0.1% | 00.0% | Unchanged | History |
| KRSAKorsana Biosciences, Inc. | COM | 552 | $2.00K | <0.1% | 00.0% | Unchanged | History |
Options (3)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q2 2023 (21)
Positions held at the end of Q2 2023 that are gone from this filing.
| Security | Class | Shares in Q2 2023 | Value in Q2 2023 | % of portfolio in Q2 2023 | History |
|---|---|---|---|---|---|
| KRYSKrystal Biotech, Inc. | COM | 349,669 | $41.1M | 1.3% | History |
| SAGESage Therapeutics, Inc. | COM | 500,000 | $23.5M | 0.8% | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 400,000 | $20.4M | 0.7% | History |
| RLAYRelay Therapeutics, Inc. | COM | 1,213,725 | $15.2M | 0.5% | History |
| PTGXProtagonist Therapeutics, Inc | COM | 500,000 | $13.8M | 0.4% | History |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 702,291 | $11.6M | 0.4% | History |
| DHRDanaher Corp | Stock | 47,500 | $11.4M | 0.4% | History |
| MRSNMersana Therapeutics, Inc. | COM | 3,029,555 | $9.97M | 0.3% | History |
| ARAVAravive, Inc. | COM | 4,572,515 | $5.76M | 0.2% | History |
| PFTAPerception Capital Corp. III | CLASS A ORD SHS | 380,000 | $3.94M | 0.1% | History |
| ALXOAlx Oncology Holdings Inc | COM | 500,000 | $3.75M | 0.1% | History |
| LCIDLucid Group, Inc. | COM | 490,000 | $3.38M | 0.1% | History |
| CGEMCullinan Therapeutics, Inc. | COM | 250,000 | $2.69M | 0.1% | History |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $2.66M | 0.1% | History |
| SANASana Biotechnology, Inc. | COM | 400,000 | $2.38M | 0.1% | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 500,000 | $1.15M | <0.1% | History |
| UTHRUnited Therapeutics Corp | COM | 2,971 | $656.0K | <0.1% | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 5,028 | $436.0K | <0.1% | History |
| KNTEKinnate Biopharma Inc. | COM | 125,000 | $379.0K | <0.1% | History |
| STERSterling Check Corp. | COM | 25,000 | $307.0K | <0.1% | History |
| CFGCitizens Financial Group Inc | COM | 10,000 | $261.0K | <0.1% | History |